CD80 and neoplasm: The expression of CD80 and CD86 co-stimulatory molecules were also decreased in the RBP-J-/- DCs compared with the RBP-J+/- DCs after the tumor antigens stimulation (Fig. 5A and 5B, middle and lower panels).